Know Cancer

or
forgot password
  • cancer clinical trials in detroit, MI

  • Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma
    Henry Ford Hospital

    Trial Locations
    Henry Ford Hospital
    Wayne State University
    Saint John Hospital and Medical Center
    Advanced Malignant Mesothelioma, Epithelial Mesothelioma, Recurrent Malignant Mesothelioma, Sarcomatous Mesothelioma
    Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma
    Saint John Hospital and Medical Center
    Detroit, Michigan 48236
    Adenocarcinoma of the Extrahepatic Bile Duct, Adenocarcinoma of the Gallbladder, Adenocarcinoma With Squamous Metaplasia of the Gallbladder, Anaplastic Carcinoma of the Gallbladder, Cholangiocarcinoma of the Extrahepatic Bile Duct, Cholangiocarcinoma of the Gallbladder, Recurrent Extrahepatic Bile Duct Cancer, Recurrent Gallbladder Cancer, Unresectable Extrahepatic Bile Duct Cancer, Unresectable Gallbladder Cancer
    Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Younger Patients With Newly Diagnosed Ependymoma
    Wayne State University

    Trial Locations
    Wayne State University
    Saint John Hospital and Medical Center
    Childhood Infratentorial Ependymoma, Childhood Supratentorial Ependymoma, Newly Diagnosed Childhood Ependymoma
    A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
    Wayne State University
    Detroit, Michigan 48202
    Breast Cancer
    Azacitidine and Entinostat in Treating Patients With Metastatic Colorectal Cancer
    Wayne State University
    Detroit, Michigan 48202
    Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IV Colon Cancer, Stage IV Rectal Cancer
    Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801)
    Karmanos Cancer Institute/Children's Hospital of Michigan
    Detroit, Michigan 48201
    Chronic GVHD
    Phase II Pazopanib in Combination With Weekly Paclitaxel in Refractory Urothelial Cancer
    Karmanos Cancer Institute
    Detroit, Michigan 48201
    Bladder Cancer, Bladder (Urothelial, Transitional Cell) Cancer, Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive), Bladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy), Bladder (Urothelial, Transitional Cell) Cancer Metastatic or Unresectable
    Phase II Study of Afinitor vs. Sutent in Patients With Metastatic Non-Clear Cell Renal Cell Carcinoma
    Karmanos Cancer Institute/Wayne State University
    Detroit, Michigan
    Advanced Non-clear Cell Renal Cell Carcinoma
    Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702)
    Karmanos Cancer Institute/BMT
    Detroit, Michigan 48201
    Multiple Myeloma
    PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma
    Henry Ford Hospital
    Detroit, Michigan 48202
    Glioblastoma, GBM, Glioblastoma Multiforme
    Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis
    Karmanos Cancer Institute
    Detroit, Michigan 48201
    Sickle Cell Disease, Vaso-occlusive Crisis, Pain Crisis
    Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    Barbara Ann Karmanos Cancer Institute

    Trial Locations
    Barbara Ann Karmanos Cancer Institute
    Josephine Ford Cancer Center at Henry Ford Hospital
    Kidney Cancer
    Xeroderma Pigmentosum Patient Experiences
    Henry Ford Medical Center, New Center One
    Detroit, Michigan 48202
    Xeroderma Pigmentosum
    Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
    Barbara Ann Karmanos Cancer Institute

    Trial Locations
    Barbara Ann Karmanos Cancer Institute
    Josephine Ford Cancer Center at Henry Ford Hospital
    Breast Cancer
    Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
    Saint John Hospital and Medical Center
    Detroit, Michigan 48236
    Recurrent Melanoma, Stage III Melanoma, Stage IV Melanoma
    Imetelstat as Maintenance Therapy After Initial Induction Chemotherapy in Non-small Cell Lung Cancer (NSCLC)
    Karmanos Cancer Institute
    Detroit, Michigan 48201
    Non-small Cell Lung Cancer
    Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer
    Barbara Ann Karmanos Cancer Institute
    Detroit, Michigan 48201
    Breast Cancer, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment
    Investigational Site Number 840004
    Detroit, Michigan 48201
    Neoplasm Malignant
    Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
    Saint John Hospital and Medical Center
    Detroit, Michigan 48236
    Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Recurrent Esophageal Cancer, Squamous Cell Carcinoma of the Esophagus, Stage IV Esophageal Cancer
    Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Barbara Ann Karmanos Cancer Institute
    Detroit, Michigan 48201
    Leukemia
    Extension Study to Evaluate the Long-term Efficacy and Safety of Everolimus in Liver Transplant Recipients
    Henry Ford Hospital Transplant Institute
    Detroit, Michigan 48202
    Liver Transplant Recipient
    Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia
    Wayne State University
    Detroit, Michigan 48202
    Childhood Hepatoblastoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Malignant Germ Cell Tumor, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Neuroblastoma, Recurrent Osteosarcoma, Recurrent Wilms Tumor and Other Childhood Kidney Tumors
    A Study of a Retroviral Replicating Vector Administered to Subjects With Recurrent Malignant Glioma
    Henry Ford Hospital
    Detroit, Michigan 48202
    Glioblastoma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Anaplastic Oligoastrocytoma
    Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Henry Ford Hospital

    Trial Locations
    Henry Ford Hospital
    Wayne State University
    Saint John Hospital and Medical Center
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Vorinostat in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma
    Barbara Ann Karmanos Cancer Institute
    Detroit, Michigan 48201
    Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Salivary Gland Cancer, Salivary Gland Adenoid Cystic Carcinoma, Stage III Adenoid Cystic Carcinoma of the Oral Cavity, Stage III Salivary Gland Cancer, Stage IV Adenoid Cystic Carcinoma of the Oral Cavity, Stage IV Salivary Gland Cancer, Tongue Cancer
    A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia
    Children's Hospital of Michigan
    Detroit, Michigan 48201
    Sickle Cell Anemia, Sickle ß0-Thalassemia
    Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG)
    Children's Hospital of Michigan
    Detroit, Michigan 48201
    Diffuse Intrinsic Pontine Glioma
    Vorinostat and Radiation Therapy Followed By Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Pontine Glioma
    Saint John Hospital and Medical Center
    Detroit, Michigan 48236
    Childhood Mixed Glioma, Untreated Childhood Brain Stem Glioma
    Risk-Adapted Chemotherapy in Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia
    Wayne State University

    Trial Locations
    Wayne State University
    Saint John Hospital and Medical Center
    B-cell Childhood Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer
    Saint John Hospital and Medical Center
    Detroit, Michigan 48236
    Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Stage IB Esophageal Cancer, Stage IIA Esophageal Cancer, Stage IIB Esophageal Cancer, Stage IIIA Esophageal Cancer, Stage IIIB Esophageal Cancer
    Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Clear Cell Ovarian Cancer
    Saint John Hospital and Medical Center
    Detroit, Michigan 48236
    Ovarian Clear Cell Cystadenocarcinoma, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
    Henry Ford Hospital

    Trial Locations
    Henry Ford Hospital
    Wayne State University
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    PET Scanning to Evaluate Zoledronate Efficacy in Metastatic Prostate Cancer
    Barbara Ann Karmanos Cancer Institute
    Detroit, Michigan 48201
    Prostate Cancer
    Human Papilloma Virus (HPV) Type-Specific Antibody
    Wayne State University/Children's Hospital of Michigan NICHD CRS (5041)
    Detroit, Michigan 48201
    Papilloma Virus, Human
    PONATINIB for Chronic Myeloid Leukemia (CML) Evaluation and Ph+ Acute Lymphoblastic Leukemia (ALL)
    Karmanos Cancer Institute, Site # 034
    Detroit, Michigan 48201
    Chronic Myeloid Leukemia (CML), Ph+ Acute Lymphoblastic Leukemia (ALL)
    Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65
    Barbara Ann Karmanos Cancer Institute
    Detroit, Michigan 48201
    Multiple Myeloma
    Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
    Barbara Ann Karmanos Cancer Center
    Detroit, Michigan 48201
    Amyloidosis
    Study of Intravenous TCD-717 in Patients With Advanced Solid Tumors
    Barbara Ann Karmanos Cancer Institute
    Detroit, Michigan 48201
    Advanced Solid Tumors
    Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors
    Wayne State University
    Detroit, Michigan 48202
    Recurrent Childhood Medulloblastoma, Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor